 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hormone/growth factor
|
PDB id
|
|
|
|
1q1u
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biochemical function
|
growth factor activity
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
278:34226-34236
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs.
|
|
S.K.Olsen,
M.Garbi,
N.Zampieri,
A.V.Eliseenkova,
D.M.Ornitz,
M.Goldfarb,
M.Mohammadi.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Fibroblast growth factors (FGFs) interact with heparan sulfate
glycosaminoglycans and the extracellular domains of FGF cell surface receptors
(FGFRs) to trigger receptor activation and biological responses. FGF homologous
factors (FHF1-FHF4; also known as FGF11-FGF14) are related to FGFs by
substantial sequence homology, yet their only documented interactions are with
an intracellular kinase scaffold protein, islet brain-2 (IB2) and with
voltage-gated sodium channels. In this report, we show that recombinant FHFs can
bind heparin with high affinity like classical FGFs yet fail to activate any of
the seven principal FGFRs. Instead, we demonstrate that FHFs bind IB2 directly,
furthering the contention that FHFs and FGFs elicit their biological effects by
binding to different protein partners. To understand the molecular basis for
this differential target binding specificity, we elucidated the crystal
structure of FHF1b to 1.7-A resolution. The FHF1b core domain assumes a
beta-trefoil fold consisting of 12 antiparallel beta strands (beta 1 through
beta 12). The FHF1b beta-trefoil core is remarkably similar to that of classical
FGFs and exhibits an FGF-characteristic heparin-binding surface as attested to
by the number of bound sulfate ions. Using molecular modeling and
structure-based mutational analysis, we identified two surface residues, Arg52
in the beta 4-beta 5 loop and Val95 in the beta 9 strand of FHF1b that are
required for the interaction of FHF1b with IB2. These two residues are unique to
FHFs, and mutations of the corresponding residues of FGF1 to Arg and Val
diminish the capacity of FGF1 to activate FGFRs, suggesting that these two FHF
residues contribute to the inability of FHFs to activate FGFRs. Hence, FHFs and
FGFs bear striking structural similarity but have diverged to direct related
surfaces toward interaction with distinct protein targets.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
FIG. 3. FHF1b binds IB2 directly. Recombinant FHFs were
mixed with partially purified mIB2[226-421] at a 1:3 molar ratio
and chromatographed through a Superdex 75 gel filtration column.
Fractions were analyzed by SDS-PAGE followed by silver staining.
A, FHF1b only; B, FHF1b + mIB2[226-421]; C, FHF4b only; D, FHF4b
+ mIB2[226-421]; E, FHF1b[1-142]. Wild-type FHFs alone elute
slowly, whereas they co-elute rapidly when complexed with
mIB2[226-421].
|
 |
Figure 5.
FIG. 5. Comparison of FHF1b versus FGF structure. A, stereo
view of FHF1b-FGF9 overlay. The C trace of FGF9 -trefoil
(blue) was superimposed onto the C trace of the FHF1b -trefoil
(orange). The N and C termini are labeled NT and CT,
respectively. The [8]- [9] turn of the ligands
(discussed under "Results") are marked by an arrowhead. This
figure was created using the program MolScript (59). B, stereo
view of the electron density map of the FHF1b heparin-binding
site. The 2F[o]-F[c] electron density map (contoured at 1.2 ) is
shown as white (FHF1b) and cyan (sulfate ions) wire mesh. The
FHF1b -trefoil core is shown
as a ribbon diagram, and residues that interact with the sulfate
ions are rendered as sticks. Ordered sulfate ions are also
rendered as sticks. This figure was created using the program
PyMOL (56).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2003,
278,
34226-34236)
copyright 2003.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
N.A.Sunmonu,
K.Li,
and
J.Y.Li
(2011).
Numerous isoforms of Fgf8 reflect its multiple roles in the developing brain.
|
| |
J Cell Physiol, 226,
1722-1726.
|
 |
|
|
|
|
 |
D.C.Tomlinson,
and
M.A.Knowles
(2010).
Altered splicing of FGFR1 is associated with high tumor grade and stage and leads to increased sensitivity to FGF1 in bladder cancer.
|
| |
Am J Pathol, 177,
2379-2386.
|
 |
|
|
|
|
 |
S.Tulin,
and
A.Stathopoulos
(2010).
Extending the family table: Insights from beyond vertebrates into the regulation of embryonic development by FGFs.
|
| |
Birth Defects Res C Embryo Today, 90,
214-227.
|
 |
|
|
|
|
 |
V.Knights,
and
S.J.Cook
(2010).
De-regulated FGF receptors as therapeutic targets in cancer.
|
| |
Pharmacol Ther, 125,
105-117.
|
 |
|
|
|
|
 |
A.Beenken,
and
M.Mohammadi
(2009).
The FGF family: biology, pathophysiology and therapy.
|
| |
Nat Rev Drug Discov, 8,
235-253.
|
 |
|
|
|
|
 |
F.M.Vaccarino,
E.L.Grigorenko,
K.M.Smith,
and
H.E.Stevens
(2009).
Regulation of cerebral cortical size and neuron number by fibroblast growth factors: implications for autism.
|
| |
J Autism Dev Disord, 39,
511-520.
|
 |
|
|
|
|
 |
M.S.Razzaque
(2009).
FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player?
|
| |
Am J Physiol Renal Physiol, 296,
F470-F476.
|
 |
|
|
|
|
 |
P.Krejci,
J.Prochazkova,
V.Bryja,
A.Kozubik,
and
W.R.Wilcox
(2009).
Molecular pathology of the fibroblast growth factor family.
|
| |
Hum Mutat, 30,
1245-1255.
|
 |
|
|
|
|
 |
R.Goetz,
K.Dover,
F.Laezza,
N.Shtraizent,
X.Huang,
D.Tchetchik,
A.V.Eliseenkova,
C.F.Xu,
T.A.Neubert,
D.M.Ornitz,
M.Goldfarb,
and
M.Mohammadi
(2009).
Crystal structure of a fibroblast growth factor homologous factor (FHF) defines a conserved surface on FHFs for binding and modulation of voltage-gated sodium channels.
|
| |
J Biol Chem, 284,
17883-17896.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Lea,
N.Papalopulu,
E.Amaya,
and
K.Dorey
(2009).
Temporal and spatial expression of FGF ligands and receptors during Xenopus development.
|
| |
Dev Dyn, 238,
1467-1479.
|
 |
|
|
|
|
 |
V.G.Shakkottai,
M.Xiao,
L.Xu,
M.Wong,
J.M.Nerbonne,
D.M.Ornitz,
and
K.A.Yamada
(2009).
FGF14 regulates the intrinsic excitability of cerebellar Purkinje neurons.
|
| |
Neurobiol Dis, 33,
81-88.
|
 |
|
|
|
|
 |
E.M.Schaeffer,
L.Marchionni,
Z.Huang,
B.Simons,
A.Blackman,
W.Yu,
G.Parmigiani,
and
D.M.Berman
(2008).
Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer.
|
| |
Oncogene, 27,
7180-7191.
|
 |
|
|
|
|
 |
F.Forconi,
G.Poretti,
I.Kwee,
E.Sozzi,
D.Rossi,
P.M.Rancoita,
D.Capello,
A.Rinaldi,
E.Zucca,
D.Raspadori,
V.Spina,
F.Lauria,
G.Gaidano,
and
F.Bertoni
(2008).
High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia.
|
| |
Br J Haematol, 141,
622-630.
|
 |
|
|
|
|
 |
F.Nakayama,
K.Müller,
A.Hagiwara,
R.Ridi,
M.Akashi,
and
V.Meineke
(2008).
Involvement of intracellular expression of FGF12 in radiation-induced apoptosis in mast cells.
|
| |
J Radiat Res (Tokyo), 49,
491-501.
|
 |
|
|
|
|
 |
G.R.Uhl
(2008).
Addiction Reviews. Preface.
|
| |
Ann N Y Acad Sci, 1141,
ix-ix.
|
 |
|
|
|
|
 |
S.Fukumoto
(2008).
Actions and mode of actions of FGF19 subfamily members.
|
| |
Endocr J, 55,
23-31.
|
 |
|
|
|
|
 |
S.Fukumoto
(2008).
Physiological regulation and disorders of phosphate metabolism--pivotal role of fibroblast growth factor 23.
|
| |
Intern Med, 47,
337-343.
|
 |
|
|
|
|
 |
T.Hubert,
S.Bourane,
S.Ventéo,
I.Mechaly,
S.Puech,
J.Valmier,
P.Carroll,
and
A.Fichard-Carroll
(2008).
Fibroblast growth factor homologous factor 1 (FHF1) is expressed in a subpopulation of calcitonin gene-related peptide-positive nociceptive neurons in the murine dorsal root ganglia.
|
| |
J Comp Neurol, 507,
1588-1601.
|
 |
|
|
|
|
 |
M.Goldfarb,
J.Schoorlemmer,
A.Williams,
S.Diwakar,
Q.Wang,
X.Huang,
J.Giza,
D.Tchetchik,
K.Kelley,
A.Vega,
G.Matthews,
P.Rossi,
D.M.Ornitz,
and
E.D'Angelo
(2007).
Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels.
|
| |
Neuron, 55,
449-463.
|
 |
|
|
|
|
 |
M.K.Stachowiak,
P.A.Maher,
and
E.K.Stachowiak
(2007).
Integrative nuclear signaling in cell development--a role for FGF Receptor-1.
|
| |
DNA Cell Biol, 26,
811-826.
|
 |
|
|
|
|
 |
A.Canales,
R.Lozano,
B.López-Méndez,
J.Angulo,
R.Ojeda,
P.M.Nieto,
M.Martín-Lomas,
G.Giménez-Gallego,
and
J.Jiménez-Barbero
(2006).
Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue.
|
| |
FEBS J, 273,
4716-4727.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.M.Rush,
E.K.Wittmack,
L.Tyrrell,
J.A.Black,
S.D.Dib-Hajj,
and
S.G.Waxman
(2006).
Differential modulation of sodium channel Na(v)1.6 by two members of the fibroblast growth factor homologous factor 2 subfamily.
|
| |
Eur J Neurosci, 23,
2551-2562.
|
 |
|
|
|
|
 |
W.Zhong,
Q.T.Wang,
T.Sun,
F.Wang,
J.Liu,
R.Leach,
A.Johnson,
E.E.Puscheck,
and
D.A.Rappolee
(2006).
FGF ligand family mRNA expression profile for mouse preimplantation embryos, early gestation human placenta, and mouse trophoblast stem cells.
|
| |
Mol Reprod Dev, 73,
540-550.
|
 |
|
|
|
|
 |
X.Zhang,
O.A.Ibrahimi,
S.K.Olsen,
H.Umemori,
M.Mohammadi,
and
D.M.Ornitz
(2006).
Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.
|
| |
J Biol Chem, 281,
15694-15700.
|
 |
|
|
|
|
 |
J.Kim,
J.Lee,
S.R.Brych,
T.M.Logan,
and
M.Blaber
(2005).
Sequence swapping does not result in conformation swapping for the beta4/beta5 and beta8/beta9 beta-hairpin turns in human acidic fibroblast growth factor.
|
| |
Protein Sci, 14,
351-359.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Y.Lou,
F.Laezza,
B.R.Gerber,
M.Xiao,
K.A.Yamada,
H.Hartmann,
A.M.Craig,
J.M.Nerbonne,
and
D.M.Ornitz
(2005).
Fibroblast growth factor 14 is an intracellular modulator of voltage-gated sodium channels.
|
| |
J Physiol, 569,
179-193.
|
 |
|
|
|
|
 |
M.Goldfarb
(2005).
Fibroblast growth factor homologous factors: evolution, structure, and function.
|
| |
Cytokine Growth Factor Rev, 16,
215-220.
|
 |
|
|
|
|
 |
M.Mohammadi,
S.K.Olsen,
and
O.A.Ibrahimi
(2005).
Structural basis for fibroblast growth factor receptor activation.
|
| |
Cytokine Growth Factor Rev, 16,
107-137.
|
 |
|
|
|
|
 |
M.Kawano,
S.Suzuki,
M.Suzuki,
J.Oki,
and
T.Imamura
(2004).
Bulge- and basal layer-specific expression of fibroblast growth factor-13 (FHF-2) in mouse skin.
|
| |
J Invest Dermatol, 122,
1084-1090.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|